OKYO Pharma Ltd (OKYO)

London
3.250
-0.600(-15.58%)
  • Volume:
    436,282
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    3.250 - 3.250

OKYO Overview

Prev. Close
3.85
Day's Range
3.25-3.25
Revenue
-
Open
3.55
52 wk Range
3.25-9
EPS
-0.01
Volume
436,282
Market Cap
49.53M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
270,125
P/E Ratio
-
Beta
-1.36
1-Year Change
-38.4%
Shares Outstanding
1,415,040,468
Next Earnings Date
-
What is your sentiment on OKYO Pharma?
or
Market is currently closed. Voting is open during market hours.

OKYO Pharma Ltd Company Profile

OKYO Pharma Ltd Company Profile

Employees
6

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell